Ekaterina Dadachova

Professor of Pharmacy, Chair in Radiopharmacy

University of Saskatchewan

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ekaterina Dadachova is a Professor of Pharmacy and Chair in Radiopharmacy at the University of Saskatchewan, Canada. Her research primarily focuses on radiopharmacy, including the development of radioimmunotherapy techniques and the biological effects of radiation. Recent publications explore various aspects of radioligand therapy and the pharmacokinetics of engineered antibody variants.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ekaterina Dadachova

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Correction to “In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy”

Combination of Radioligand Therapy and Immunotherapy: How to Make It Work in Clinic?

Musculoskeletal perturbations of deep space radiation: Assessment using a Gateway MRI

In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy

Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R)

Radioimmunotherapy as a pathogen-agnostic treatment method for opportunistic mucormycosis infections

Mitigating effects of sublethal and lethal whole-body gamma irradiation in a mouse model with soluble melanin

Melanin – protecting and enhancing the earliest life on Earth

225Ac‐labeled CD33‐targeting antibody reverses resistance to Bcl‐2 inhibitor venetoclax in acute myeloid leukemia models

Collaborators (6)

Philip Chilibeck

Gordon Sarty

James Johnston

Maruti Uppalapati

Saija Kontulainen

Connor Frank

Make your next move.